Samir Ahuja, MD
Obstetrics & Gynecology · Mentor, OHNPI 1497850622
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $311,320 of the $429,862 with a category attached, or 72.4%. AbbVie accounts for 72.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $138,287 and has fallen 98.6% since, to $1,906 in 2025. Among obstetrics & gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 737 payments — averaging $583.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$313K
- Myovant Sciences Inc.$61K
- Sumitomo Pharma America, Inc.$26K
- Bayer$23K
- Pfizer$5K
- Astellas Pharma US Inc$419
- plus $1K from 19 others
What the payments were for
- Consulting fees$27,2486%
- Speaking & faculty fees$311,32072%
- Travel & lodging$78,90318%
- Food & beverage$12,3263%
- Education$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 435 | $313,079 |
| Myovant Sciences Inc. | 92 | $61,223 |
| Sumitomo Pharma America, Inc. | 37 | $25,868 |
| Bayer | 55 | $22,772 |
| Pfizer | 18 | $5,055 |
| Astellas Pharma US Inc | 23 | $419 |
| Therapeuticsmd, Inc. | 13 | $208 |
| Exeltis, USA Inc. | 10 | $187 |
| Optumhealth Care Solutions, LLC | 8 | $171 |
| Millicent US Inc | 8 | $155 |
| Mayne Pharma Commercial LLC | 6 | $127 |
| Shield Therapeutics Inc | 6 | $105 |
| Gynesonics, Inc. | 1 | $81 |
| Axonics, Inc. | 4 | $78 |
| AMAG Pharmaceuticals, Inc. | 4 | $66 |
| Aspira Women's Health Inc | 2 | $62 |
| Lupin Inc. | 3 | $43 |
| Evofem Biosciences, Inc. | 2 | $31 |
| Meditrina | 2 | $27 |
| Coopersurgical, Inc. | 2 | $25 |
| Duchesnay USA Incorporated | 2 | $24 |
| Novo Nordisk | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $14 |
| Minerva Surgical, Inc | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$429,862 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 74 | $3,634 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $216 |
| Medroxyprogesterone Acetate | 15 | $141 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Mentor
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
- David SchwartzCincinnati$169K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Lorie Thomas-SchultzFindlay$92K
- Oluwatosin GojeCleveland$81K
- Gerard ReillyCincinnati$74K
- Nicholas SherockOrrville$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.